Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 3-(pyrrolidin-1-yl)cyclobutylcarbaMate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1246739-82-1

Post Buying Request

1246739-82-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1246739-82-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1246739-82-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,7,3 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1246739-82:
(9*1)+(8*2)+(7*4)+(6*6)+(5*7)+(4*3)+(3*9)+(2*8)+(1*2)=181
181 % 10 = 1
So 1246739-82-1 is a valid CAS Registry Number.

1246739-82-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(3-pyrrolidin-1-ylcyclobutyl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl 3-(pyrrolidin-1-yl)cyclobutylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1246739-82-1 SDS

1246739-82-1Downstream Products

1246739-82-1Relevant academic research and scientific papers

TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF

-

Paragraph 1158; 1160, (2017/01/23)

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

BENZAMIDE CGRP RECEPTOR ANTAGONISTS

-

Page/Page column 234; 235, (2015/11/09)

The present invention is directed to benzamide compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

2,4-DI(AMINOPHENYL) PYRIMIDINES AS PLK INHIBITORS

-

Page/Page column 48-49, (2008/06/13)

The invention relates to compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1, and R3 are defined as indicated in claim 1. Said compounds are used for the treatment of diseases characterized by excessive or anomalous cell proliferation. Also disclosed is the use of the inventive compounds for producing a medicament having said properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1246739-82-1